News | Magnetic Resonance Imaging (MRI) | November 22, 2019

Kopp Development Inc. Acquires Mednovus, Inc.

This acquisition will expand its MRI safety product line

FerrAlert technology automatically detects and logs ferromagnetic events and exclusively provides a photographic stream which is date and time stamped

November 22, 2019 — Kopp Development Inc. acquired Mednovus, Inc. ferromagnetic detection business. With the acquisition, Kopp Development is expanding its MRI safety product line to include the hand-held FerrAlert Target Scanner line. With the addition of the hand-held detector products, Kopp now has a product for all aspects of MRI safety regarding the magnetic field of the MRI machine

In addition to the products and the FMDS technology, Kopp has acquired eight additional patents. Kopp now has 23 U.S. and international patents with more patents pending. With this intellectual property foundation, Kopp will be a technology innovator and MRI Safety leader now and in the future.

Keith Kopp, president stated: “I am very excited by this acquisition. Mednovus is a proven leader in the field. With over 2,000 detectors in use, their track record is well-established. We intend to build upon this foundation to make the MRI experience safer for all.”

Kemp Massengill, Mednovus president, said: “We are honored to pass the Mednovus baton and legacy of excellence to Keith Kopp and his exceptional Professional team at Kopp Development, the acknowledged world leader in ferromagnetic detection. This is a major safety step forward for patient care, as the synergy achieved with Kopp Development pillar and portal FMD systems and the FerrAlert Target Scanner working in tandem greatly enhances MRI Safety for the millions of patients undergoing this procedure every year.” 

FerrAlert's systems provide an accurate location of the ferromagnetic threat. FerrAlert technology automatically detects and logs ferromagnetic events and exclusively provides a photographic stream which is date and time stamped. At RSNA 2019, the company is introducing the secure Encompass Data App which is encompassing of all the company's products, allowing remote monitoring of all systems’ performance. The logging includes:

  • Date and time record of when the product was used;
  • Ferromagnetic detection;
  • The opening and closing of the door; and
  • Location of the ferromagnetic threat.

All MRI facilities are required by The Joint Commission to collect data on:

  • Incidents where ferromagnetic objects unintentionally entered the MRI scanner room
  • Injuries resulting from presence of ferromagnetic objects in the MRI scanner room 

For more information: https://koppdevelopment.com/ 

Related content:

Closing the Loopholes in MRI Safety

Thirty-Six Percent of Medical Facilities Not Compliant With MRI Safety Standards

Related Content

Flowchart of patient inclusion and exclusion.

Figure 1. Flowchart of patient inclusion and exclusion.

News | Coronavirus (COVID-19) | October 20, 2020
October 20, 2020 — A new multi-institutional study published in the journal ...
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence | October 20, 2020
October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using...
Rebrand reflects Volpara Health's mission to prevent advanced-stage breast cancer
News | Breast Imaging | October 19, 2020
October 19, 2020 — Volpara Solutions, a leader in AI-powered breast density assessment, announced that it has changed
Moffitt Cancer Center researchers are developing a noninvasive, accurate method to analyze a patient's tumor mutations and biomarkers to determine the best course of treatment.

Getty Images

News | Lung Imaging | October 19, 2020
October 19, 2020 — Personalized treatment options for patients with...
Varian, a leading provider of cancer care technologies and solutions, continues to reinforce its commitment to delivering Intelligent Cancer Care during the 2020 American Society for Radiation Oncology (ASTRO) taking place virtually Oct. 24-31.
News | ASTRO | October 19, 2020
October 19, 2020 — ...
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

56-Year-Old Woman With Benign Hemangioma: Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma.

News | Magnetic Resonance Imaging (MRI) | October 16, 2020
October 16, 2020 — 
Mevion Medical Systems announced that it has shipped the accelerator module for the Mevion S250i Proton Therapy System to Kunshan, China. The 15-ton compact accelerator, the heart of the proton therapy system, is the smallest of its kind and will be the first in China.

Mevion's compact accelerator module is lifted and placed on a truck for the first leg of its journey to China. (Photo: Business Wire)

News | Proton Therapy | October 16, 2020
October 16, 2020 — Mevion Medical Systems announced that it has shipped the accelerator module for the...